Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.

Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer J, Azodi M, Zheng W, Chambers SK.

Cancer Prev Res (Phila). 2014 Sep;7(9):896-905. doi: 10.1158/1940-6207.CAPR-13-0408. Epub 2014 Jun 20.

2.

Autocrine inhibition of the c-fms proto-oncogene reduces breast cancer bone metastasis assessed with in vivo dual-modality imaging.

Jeffery JJ, Lux K, Vogel JS, Herrera WD, Greco S, Woo HH, AbuShahin N, Pagel MD, Chambers SK.

Exp Biol Med (Maywood). 2014 Apr;239(4):404-13. doi: 10.1177/1535370214522588. Epub 2014 Mar 5.

3.

Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Gruessner C, Gruessner A, Glaser K, Abushahin N, Laughren C, Zheng W, Chambers SK.

Am J Cancer Res. 2014 Jan 15;4(1):61-72. eCollection 2014.

4.

Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.

Li J, Ning Y, Abushahin N, Yuan Z, Wang Y, Wang Y, Yuan B, Cragun JM, Chambers SK, Hatch K, Kong B, Zheng W.

Gynecol Oncol. 2013 Dec;131(3):555-60. doi: 10.1016/j.ygyno.2013.09.018. Epub 2013 Sep 20.

PMID:
24060413
5.

Tubal origin of 'ovarian' low-grade serous carcinoma.

Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B, Zheng W.

Mod Pathol. 2011 Nov;24(11):1488-99. doi: 10.1038/modpathol.2011.106. Epub 2011 Jun 24.

6.

Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.

Abushahin N, Zhang T, Chiang S, Zhang X, Hatch K, Zheng W.

Int J Gynecol Pathol. 2011 May;30(3):271-81. doi: 10.1097/PGP.0b013e318200868e.

PMID:
21464726
7.

Nrf2 expression in endometrial serous carcinomas and its precancers.

Chen N, Yi X, Abushahin N, Pang S, Zhang D, Kong B, Zheng W.

Int J Clin Exp Pathol. 2010 Dec 24;4(1):85-96.

Supplemental Content

Loading ...
Support Center